Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of a new drug- sorafenib, which is to be
administered at the same time as standard treatment, which includes hormonal therapy and
external beam radiotherapy.